Log In
Print this Print this


Also known as: mock-up flu vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSplit virion, inactivated, adjuvanted, pandemic influenza vaccine that can be modified to a pandemic strain once identified
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza
Regulatory Designation EU - Standard Review (Prevent influenza)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today